 - Any clinically relevant concomitant conditions or renal impairment characterized by serum creatinine levels 1.5xULN or hepatic impairment or alcohol abuse characterized by ALT andor aspartate transferase AST levels 3xULN andor gamma-glutamyl transpeptidase GGT levels 3xULN of the laboratory reference range. 